SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-20-000095
Filing Date
2020-04-30
Accepted
2020-04-30 16:09:19
Documents
15
Period of Report
2020-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k43020pluto.htm   iXBRL 8-K 48184
2 EXHIBIT 10.1 rightsexchangeagreement.htm EX-10.1 104667
  Complete submission text file 0001070081-20-000095.txt   319008

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20200429.xsd EX-101.SCH 4701
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20200429_cal.xml EX-101.CAL 640
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20200429_def.xml EX-101.DEF 1490
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptct-20200429_lab.xml EX-101.LAB 26468
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20200429_pre.xml EX-101.PRE 13685
13 EXTRACTED XBRL INSTANCE DOCUMENT a8k43020pluto_htm.xml XML 4272
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 20835722
SIC: 2834 Pharmaceutical Preparations